GLP-1s
Personal Trainers Say Their Jobs Are Changing Due to the Rise of GLP-1s
NASM's new survey of 500 fitness pros shows GLP-1 drugs like Ozempic are reshaping the industry and the role of personal trainers.
Pvolve Does Strength Smarter To Keep You Fit Longer
Functional fitness brand Pvolve is contributing to the increased strength training demand, longevity movement and GLP-1 boom all at once
Wearables Uncover Hidden Insights Into Overeating in New Study
A necklace, wristband and bodycam helped researchers reveal five hidden overeating styles that could shape the future of obesity treatment.
Signos Scores FDA Clearance for First OTC Glucose Monitor for Weight Loss
Signos wins FDA clearance for first OTC glucose monitor for weight management, combining Dexcom’s Stelo with AI-driven health insights.
Why Evolt Says Muscle is the New Metric in Fitness
Evolt is shifting the focus from weight loss to muscle mass in fitness and other related fields through new findings
Dr. Frank Lipman Says Longevity Science Shows Promise but ‘Not There Yet’
At the ATN Innovation Summit, functional medicine pioneer Dr. Frank Lipman shared his views on the fast-growing field of longevity science.
WeightWatchers Makes Nasdaq Comeback, Targets Menopause
WeightWatchers relists on Nasdaq and expands into menopause care as it deepens its focus on medical-grade weight management.
Post-Hims & Hers Breakup, Novo Nordisk Strengthens WeightWatchers Ties
With a pharma giant in its corner, WeightWatchers is mounting a comeback, relying on FDA-approved GLP-1 medications.
Syntis Bio Secures $38M for Weight Loss Pill That Mimics Gastric Bypass Surgery
Syntis Bio has raised $38M to advance its injectable-free, once-daily pill that mimics gastric bypass surgery.
How Evolt is Guiding GLP-1 Users Toward Safer Weight Loss
Evolt's body scanning device and other technological innovations are must-haves in this new age of fitness featuring GLP-1s
